Opinion: Kudos to Google for banning stem cell ads. Other tech companies should follow
Google took an important step this month toward restricting the reach of one breed of 21st-century snake oil purveyor: those selling stem cell treatments. Others need to follow its lead.
More than 600 clinics in the U.S. and many more around the world have co-opted the potential of using stem cell treatments to cure a range of medical conditions and now sell these treatments directly to the public despite a lack of evidence that they work as promised.
